MAPT and tauopathy: 18F-MK-6240 is a second-generation tracer that has demonstrated high affinity and selectivity to AD-type NFTs comprised of PHF tau in post-mortem AD brains and little to no binding to tau aggregates in non-AD tauopathy [75].